The 21Shares certificate tracks Anthropic's estimated private-market value, but buyers hold unsecured debt tied to a Cayman issuer and its affiliated note counterparty, not shares in the company.
A strong reference price would not shield 21Shares certificate holders if the issuer or its note counterparty failed to pay. Binance's one-second mark-price method can affect the derivative's valuation, but it does not remove that credit exposure.
The certificate's contractual issue date was Oct. 13, 2026, the day 21Shares began trading it on Vienna MTF under the ticker CLAU. The product offers synthetic exposure to Anthropic's estimated private-market value through an unlisted structured note. It gives buyers no direct ownership of the company's shares. 21Shares describes CLAU's product structure as synthetic exposure. Holders get no voting rights, and the certificate does not automatically convert into Anthropic shares at an IPO. Anthropic is not affiliated with or an approver of the product.
The initial issue comprised 5,000 certificates at $10 each. Trading on Vienna MTF is in euros. Buyers can access the product through brokers and platforms that support the venue.
That exposure rests on a note structure, not a claim to Anthropic or its derivatives. The final terms name 21shares x FalconX Limited as issuer and FalconX Sandpiper SPC as the relevant contract counterparty. Buyers hold unsecured and unsubordinated debt of the issuer. The issuer, in turn, relies on the counterparty to meet the note's contractual obligations.
A default or insolvency at the counterparty could leave the issuer with substantially less than the note's calculated value, or nothing, according to the legal summary. Certificate holders can seek recourse only from the issuer, with no guarantee from another entity. A rise in the reference price would not prevent losses if that payment chain failed.
The issuer and counterparty are affiliated within the FalconX Holdings group. According to the legal summary, group entities negotiate fixed prices and slippage. The negotiations also cover financing costs and tracking tolerances, without an independent issuer director authorized to approve whether the terms are fair. No outside party verifies that they match an arm's-length deal. The disclosure flags a potential conflict; it does not establish that any term is unfair or that anyone acted improperly. The issuer says it has conflict-management arrangements, but warns their effectiveness cannot be assured.
NAV Consulting Inc. is named as calculation agent and administrator. It calculates net asset value, a role distinct from independently reviewing whether the affiliated parties' negotiated terms are fair.
21Shares says Anthropic's mark price updates every second, using executed trades over a rolling 10-to-100-second window. The method limits movement to 1% in either direction from one second to the next. When activity slows, it uses a trailing 100-trade fallback. The company's explanation of how pre-IPO ETP pricing works describes the mark as a derivative-market measure, not a direct transaction in Anthropic shares.
In an Oct. 13 article published by 21Shares, Binance Head of Exchange and Trading Shunyet Jan described the mark-price method. FalconX manages the economic exposure through perpetual futures traded on Binance and Hyperliquid. Those contracts provide price exposure at the counterparty level. The ETP itself holds a defined FalconX note.
The pricing rules govern the mark calculation. They do not cap an investor's total loss or establish an independent appraisal of Anthropic. The final terms also name the Kaiko Anthropic USD Reference Rate and Binance's ANTHROPICUSDT funding rate as inputs to the contract's value. The certificate's NAV reflects the underlying instrument after the investor fee. Broker execution determines what an investor may receive when selling on the secondary market.
This layered pricing and settlement process shares a risk found in other hedged positions: a hedge can work economically while collateral or access fails. A prior report on collateral risk examined that separate exposure. CLAU buyers also depend on the issuer and note counterparty, alongside the risks of the derivatives market.
The final terms set an annual investor fee of 1%. Note financing can reach 3% a year, a maximum rather than a confirmed realized rate. Indicative trading costs are 50 basis points. At inception, perpetual funding was 0.005% per funding period. Trading costs are indicative, and ongoing funding varies. These amounts cannot be combined into a fixed annual all-in charge.
According to the product FAQ, underlying financing expenses pass through to NAV. Trading expenses do too, as do perpetual-funding expenses. Certificate returns can therefore diverge from the reference price before secondary-market spreads or commissions are added. The terms set a 2% redemption fee and allow additional slippage. They also permit fiat-transfer and other charges in calculating settlement. Primary subscriptions are restricted to authorized participants; the documents do not establish that every retail sale through a broker carries the same redemption fee.
21Shares says CLAU is listed on Vienna MTF in euros and is accessible through brokers and platforms that support the venue. The final terms name Virtu Financial Ireland Limited as authorized participant and market maker. The minimum trading lot is one certificate. The documents do not establish availability to U.S. investors. According to the legal summary, Swedish approval of the prospectus is not an endorsement of the securities.
On Oct. 13, the product page showed $49,397.23 in assets and 5,000 securities outstanding. It listed a $9.88 NAV per unit, alongside a performance panel dated Oct. 12. That snapshot does not establish ongoing liquidity or guarantee the price holders can get when they sell.
The FAQ says a future official exchange quote for Anthropic would be reflected in the perpetual reference. It does not trigger automatic share delivery or forced settlement. An IPO may never occur, the legal summary warns. If pricing is disrupted or the underlying instrument is terminated, the product could use an alternative valuation. It could also shift to replacement exposure or be redeemed early at a loss.
Perpetual futures have no fixed expiry, but their funding payments can change with market conditions. In this product, those payments and other note-level costs can affect NAV while the certificate tracks synthetic exposure. A holder's return depends on the reference price, the contract terms and operating costs. It also depends on whether the issuer and counterparty can pay.
